miR-629 Targets TRIM33 to Promote TGF /Smad Signaling and Metastatic Phenotypes in ccRCC
Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-14-0300
Full Text
Open PDFAbstract
Available in full text
Date
November 7, 2014
Authors
Publisher
American Association for Cancer Research (AACR)